Anales de la RANM

18 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 ACCIONES PROTECTORAS Y REPARADORAS TISULARES DEL CBD Fernández-Tresguerres Hernández JA, et al. An RANM. 2024;141(01): 12 - 20 también con el envejecimiento toda una serie de alteraciones oxidativas inflamatorias y apoptóticas ya detectadas anteriormente [54]. El tratamiento con CBD es capaz de neutralizar al menos en parte dichas alteraciones alcanzando de nuevo los valores de los animales jóvenes. Podemos concluir que el tratamiento crónico con CBD en ratas Long Evans de 15 meses tiene un efecto muy positivo a nivel del músculo, del pulmón y más significativamente en el hígado y en el sistema inmunitario disminuyendo las lesiones tisulares inducidas por el estrés oxidativo, la inflamación y la apoptosis asociadas a la edad. DECLARACIÓN DE TRANSPARENCIA Los autores/as de este artículo declaran no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. BIBIOGRAFÍA 1. López-Otín C, Blasco MA, Partridge L, Se- rrano M, Kroemer G. The hallmarks of aging. Cell. 2013; 153: 1194-1217. doi:10.1016/j. cell.2013.05.039. 2. Kireev R, Bitoun S, Cuesta S et al. Treatment protects liver of zucker rats after ischemia/ reperfusion by diminishing oxidative stress and apoptosis. Eur J Pharmacol. 2013; 701: 185-193. doi:10.1016/j.ejphar.2012.11.038. 3. Kireev RA, Vara E, Viña J, Tresguerres JAF. Melatonin and oestrogen treatments were able to improve neuroinflammation and apoptotic processes in dentate gyrus of old ovariectomized female rats. Age (Dordr). 2014; 36: 9707. doi:10.1007/s11357-014- 9707-3. 4. Dalleau S, Baradat M, Guéraud F, Huc L. Cell death and diseases related to oxidative stress: 4-Hydroxynonenal (HNE) in the ba- lance. Cell Death Differ. 2013; 20: 1615-1630. doi:10.1038/cdd.2013.138. 5. Gallelli CA, Calcagnini S, Romano A et al. Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues. Antioxidants (Basel). 2018; 7: 93. doi:10.3390/antiox7070093. 6. Vomund S, Schäfer A, Parnham MJ, Brüne B, von Knethen A. Nrf2, the master regulator of anti-oxidative responses. Int J Mol Sci. 2017; 18: 2772. doi:10.3390/ijms18122772. 7. Partridge L, Deelen J, Slagboom PE. Facing up to the global challenges of ageing. Nature. 2018; 56: 45-56. doi:10.1038/s41586-018-0457-8. 8. Steves CJ, Spector TD, Jackson SHD. Ageing, genes, environment and epigenetics: What twin studies tell us now, and in the future. Age Ageing. 2012; 41: 581-586. doi:10.1093/ ageing/afs097. 9. Di Micco R, Krizhanovsky V, Baker D, d’Adda di Fagagna, F. Cellular senescence in ageing: From mechanisms to therapeutic opportuni- ties. Nat Rev Mol Cell Biol. 202; 22: 75-95. doi:10.1038/s41580-020-00314-w. 10. Tresguerres JAF, Kireev R, Forman K, Cuesta S, Tresguerres AF, Vara E. Effect of chronic melatonin administration on several physio- logical parameters from old wistar rats and SAMP8 mice. Curr Aging Sci. 2012; 5: 242- 253. doi:10.2174/1874609811205030012. 11. Paredes SD, Rancan L, Kireev R et al. Mela- tonin counteracts at a transcriptional level the inflammatory and apoptotic response secondary to ischemic brain injury induced by middle cerebral artery blockade in aging rats. Biores Open Access. 2015; 4(1): 407-416. doi:10.1089/biores.2015.0032. 12. Paredes SD, Rancan L, Cruz García M, Vara E, Tresguerres JAF. Resveratrol and aging. En: Joseph M Wu and Tze-chen Hsieh, edi- tors. Resveratrol: State-of-the-art science and health applications. Singapore: World Scienti- fic; 2018; p. 257-273. 13. Oh YT, Lee JY, Lee J, Lee JH, Kim J-E, Ha J, Kang I. Oleamide suppresses lipopolysaccha- ride-induced expression of iNOS and COX-2 through Inhibition of NF-kappaB activation in BV2 murine microglial cells. Neurosci Lett. 2010; 474: 148-153. doi:10.1016/j.neu- let.2010.03.026. 14. Pan H, Mukhopadhyay P, Rajesh M. Cannabi- diol attenuates cisplatin-induced nephrotoxi- city by decreasing oxidative/nitrosative stress, inflammation, and cell death. J Pharmacol Exp Ther. 2009; 328: 708-714. doi:10.1124/ jpet.108.147181. 15. Zuardi AW. History of cannabis as a medicine: a review. Braz J Psychiatry. 2006; 28: 153-157. doi:10.1590/s1516-44462006000200015. 16. Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory pro- perties of cannabidiol. Antioxidants (Basel). 2019; 9: 21. doi:10.3390/antiox9010021. 17. Bonini SA, Premoli M, Tambaro S et al. Can- nabis sativa: a comprehensive ethnopharma- cological review of a medicinal plant with a long history. J Ethnopharmacol. 2018; 227: 300-315. doi:10.1016/j.jep.2018.09.004. 18. Lintzeris N, Driels J, Elias N, Arnold JC, Mc- Gregor IS, Allsop DJ. Medicinal cannabis in Australia, 2016: the cannabis as medicine sur- vey (CAMS-16). Med J Aust. 2018; 20: 211- 216. doi:10.5694/mja17.01247. 19. Tham M, Yilmaz O, Alaverdashvili M, Kelly MEM, Denovan-Wright EM, Laprairie RB. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid recep- tors. Br J Pharmacol. 2019; 176: 1455-1469. doi:10.1111/bph.14440. 20. Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol. 2007; 556: 75-83. doi:10.1016/j.ejphar.2006.11.006.